Inclisiran: A First-in-Class siRNA Therapy for Lowering Low-Density Lipoprotein Cholesterol – PubMed
A welcome new class of cholesterol Rx
A welcome new class of cholesterol Rx
Dr. Cavalli was honored for his accomplishments in the fields of leukemia, lymphoma, and breast cancer.
Researchers aimed to identify prognostic and predictive biomarkers for adjuvant anti-PD-1 therapy in patients with macroscopic stage III melanoma.
Two thirds of patients responded to CAR T-cell therapy
Although an aerobic cooldown indeed lowers blood glucose levels in adults with type 1 diabetes after fasted exercise, by itself, the impact it has on…
A CME series highlights the three main methodologies for applying machine learning to medicine. Learn more with the AMA.
The condition can cause spine fractures and leave patients permanently disabled, yet patients are not receiving diagnoses or treatment owing to lack of awareness and…
Background and ObjectivesKnowledge of young-onset Alzheimer disease in adults with Down syndrome has greatly improved clinical care. However, little is known about dementia in rare…
Psoralen + ultraviolet-A (PUVA) is associated with photocarcinogenesis. However, carcinogenic risk with other ultraviolet phototherapies remains unclear.
The weight loss drug semaglutide may offer cardiovascular benefits for people with overweight and obesity that is independent of weight loss, according to researchers from…
Extracorporeal cardiopulmonary resuscitation (ECPR) can improve survival for refractory out-of-hospital cardiac arrest (OHCA). We sought to assess the feasibility of a proposed ECPR programme in…